help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-116-4-1473
Endocrinology Vol. 116, No. 4 1473-1484
Copyright © 1985 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PERROT-APPLANAT, M.
Right arrow Articles by MILGROM, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PERROT-APPLANAT, M.
Right arrow Articles by MILGROM, E.

Immunocytochemical Study of Mammalian Progesterone Receptor Using Monoclonal Antibodies*

M. PERROT-APPLANAT, F. LOGEAT, M. T. GROYER-PICARD and E. MILGROM

Groupe de Recherches sur la Biochimie Endocrinienne et la Reproduction INSERM U.135, Faculté de Médecine Paris-Sud, 94270 Le Kremlin-Bicetre, France

Address requests for reprints to: Dr. M. Perrot-Applanat, INSERM U. 135, Universite Paris-Sud, Faculte de Medecine de Bicetre 78, rue du General Leclerc, Le Kremlin-Bicetre 94270 France.

Abstract

Five monoclonal antibodies were used for the immunocytochemical study of mammalian progesterone receptor (PR). Initial studies were aimed at defining the optimal experimental conditions for the detection of the receptor, with special emphasis on techniques likely to be used in clinical determinations and in immunoelectron microscopic localization. Specific immunoperoxidase staining was observed either in fixed, frozen sections or in sections of paraffin-embedded tissue. The latter method allowed a better preservation of cellular structures. Among the eight fixatives tested, glutaraldehyde, picric-acid formaldehyde, and paraformaldehyde proved satisfactory. Both indirect immunoperoxidase and the indirect antibody peroxidase-antiperoxidase methods could be used.

In immature rabbits or castrated guinea pigs primed by estrogen, i.e. in conditions where its ligand was absent (or present in very low concentration), the PR was confined to the nucleus of immunoreactive cells. This was the case for all the cell types of the endometrium and the myometrium, for the immunostained cells of the oviduct, cervix, vagina, pituitary gland, and for the very weakly stained cells in the liver. No staining was observed in nontarget tissues for progesterone, such as diaphragm, spleen, and small intestine. Nuclear staining was also absent when various control antibodies replaced anti-PR antibodies. This result thus generalizes the observations made on the estrogen receptor, showing that there is no translocation of the receptor from cytoplasm to nucleus under the influence of the hormone. Moreover, a marked heterogeneity in immunostaining was observed among cells of the same type in several tissues, suggesting that there could be large differences in the hormonal sensitivity of individual cells.

Cellular distribution of PR immunoreactivity was studied in the uterus, cervix, oviduct, and pituitary gland of rabbits and in the uterus and vagina of guinea pigs. A labeling was observed in all the cell types of the uterus (luminal and glandular epithelium, stroma, and muscularis). In the cervix, nuclear immunostaining was observed in the connective tissue of the lamina propria and in some epithelial and muscle cells. In the vagina, PR immunoreactivity was seen in the basal layers of the stratified squamous epithelium, in the connective tissue of the lamina propria, and in the smooth muscle. In the oviduct, the luminal epithelium, the connective tissue, and the muscularis were stained. In the pituitary gland, selective nuclear labeling was observed in a few scattered cells. (Endocrinology 116: 1473–1484, 1985)

Footnotes

* This work was supported by the Institut National de la Sante et de la Recherche Medicale (PRC 135050), the Centre National de la Recherche Scientifique, the Fondation pour la Recherche Médicale, and the Unité d' Enseignement et de Recherches Kremlin-Bicetre.

Received July 24, 1984.




This article has been cited by other articles:


Home page
Vet PatholHome page
J. Martin de las Mulas, Y. Millan, and R. Dios
A Prospective Analysis of Immunohistochemically Determined Estrogen Receptor {alpha}and Progesterone Receptor Expression and Host and Tumor Factors as Predictors of Disease-free Period in Mammary Tumors of the Dog
Vet. Pathol., February 1, 2005; 42(2): 200 - 212.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. J. Peluso, A. Pappalardo, G. Fernandez, and C. A. Wu
Involvement of an Unnamed Protein, RDA288, in the Mechanism through which Progesterone Mediates Its Antiapoptotic Action in Spontaneously Immortalized Granulosa Cells
Endocrinology, June 1, 2004; 145(6): 3014 - 3022.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Botos, W. Xian, D. F. Smith, and C. L. Smith
Progesterone Receptor Deficient in Chromatin Binding Has an Altered Cellular State
J. Biol. Chem., April 9, 2004; 279(15): 15231 - 15239.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. Wan, K. K. Coxe, V. G. Thackray, P. R. Housley, and S. K. Nordeen
Separable Features of the Ligand-Binding Domain Determine the Differential Subcellular Localization and Ligand-Binding Specificity of Glucocorticoid Receptor and Progesterone Receptor
Mol. Endocrinol., January 1, 2001; 15(1): 17 - 31.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
D. M. Ozanne, M. E. Brady, S. Cook, L. Gaughan, D. E. Neal, and C. N. Robson
Androgen Receptor Nuclear Translocation Is Facilitated by the f-Actin Cross-Linking Protein Filamin
Mol. Endocrinol., October 1, 2000; 14(10): 1618 - 1626.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
R. K. Tyagi, Y. Lavrovsky, S. C. Ahn, C. S. Song, B. Chatterjee, and A. K. Roy
Dynamics of Intracellular Movement and Nucleocytoplasmic Recycling of the Ligand-Activated Androgen Receptor in Living Cells
Mol. Endocrinol., August 1, 2000; 14(8): 1162 - 1174.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. M. Enger, R. K. Ross, A. Paganini-Hill, C. L. Carpenter, and L. Bernstein
Body Size, Physical Activity, and Breast Cancer Hormone Receptor Status: Results from Two Case-Control Studies
Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 681 - 687.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
I. V. Smirnova, D. C. Bittel, R. Ravindra, H. Jiang, and G. K. Andrews
Zinc and Cadmium Can Promote Rapid Nuclear Translocation of Metal Response Element-binding Transcription Factor-1
J. Biol. Chem., March 24, 2000; 275(13): 9377 - 9384.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. D. Galigniana, J. L. Scruggs, J. Herrington, M. J. Welsh, C. Carter-Su, P. R. Housley, and W. B. Pratt
Heat Shock Protein 90-Dependent (Geldanamycin-Inhibited) Movement of the Glucocorticoid Receptor through the Cytoplasm to the Nucleus Requires Intact Cytoskeleton
Mol. Endocrinol., December 1, 1998; 12(12): 1903 - 1913.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
R. K. Tyagi, L. Amazit, P. Lescop, E. Milgrom, and A. Guiochon-Mantel
Mechanisms of Progesterone Receptor Export from Nuclei: Role of Nuclear Localization Signal, Nuclear Export Signal, and Ran Guanosine Triphosphate
Mol. Endocrinol., November 1, 1998; 12(11): 1684 - 1695.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
J. D. Graham and C. L. Clarke
Physiological Action of Progesterone in Target Tissues
Endocr. Rev., August 1, 1997; 18(4): 502 - 519.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
W. B. Pratt and D. O. Toft
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones
Endocr. Rev., June 1, 1997; 18(3): 306 - 360.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. K. Owens-Grillo, M. J. Czar, K. A. Hutchison, K. Hoffmann, G. H. Perdew, and W. B. Pratt
A Model of Protein Targeting Mediated by Immunophilins and Other Proteins That Bind to hsp90 via Tetratricopeptide Repeat Domains
J. Biol. Chem., June 7, 1996; 271(23): 13468 - 13475.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M Perrot-Applanat, C Cibert, G Geraud, J. Renoir, and E. Baulieu
The 59 kDa FK506-binding protein, a 90 kDa heat shock protein binding immunophilin (FKBP59-HBI), is associated with the nucleus, the cytoskeleton and mitotic apparatus
J. Cell Sci., January 5, 1995; 108(5): 2037 - 2051.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
S Dauvois, R White, and M. Parker
The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling
J. Cell Sci., January 12, 1993; 106(4): 1377 - 1388.
[Abstract] [PDF]


Home page
DevelopmentHome page
D. Hill, C. Ragsdale, and J. Brockes
Isoform-specific immunological detection of newt retinoic acid receptor delta 1 in normal and regenerating limbs
Development, January 3, 1993; 117(3): 937 - 945.
[Abstract] [PDF]


Home page
ScienceHome page
B Gametchu
Glucocorticoid receptor-like antigen in lymphoma cell membranes: correlation to cell lysis
Science, April 24, 1987; 236(4800): 456 - 461.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1985 by The Endocrine Society